Receipt of glucose testing and performance of two us diabetes screening guidelines, 2007-2012

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Bullard, Kai McKeever ^a   Ali, Mohammed K ^a   Imperatore, Giuseppina ^a   Geiss, Linda S ^a   Saydah, Sharon H ^a   Albu, Jeanine B ^b   Cowie, Catherine C ^c   Sohler, Nancy ^d   Albright, Ann ^a   Gregg, Edward W ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DYSGLYCEMIA; DYSLIPIDEMIA; ETHNICITY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; PREVALENCE; QUALITY CONTROL; REVIEW; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; UNITED STATES; ANALYSIS; BLOOD; DIET RESTRICTION; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; STATISTICS AND NUMERICAL DATA;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE;

EID: 84957837324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125249     Document Type: Review

References (36)

1. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: US Department of Health and Human Services; 2014.
2. Yang W, Dall TM, Halder P, Gallo P, Kowal SL, Hogan PF. Economic costs of diabetes in the U. S. in 2012. Diabetes Care. 2013;36(4):1033-46. doi: 10.2337/dc12-2625 PMID: 23468086
3. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and metaanalysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305-12. PMID: 17601626
4. Li Y, Geiss LS, Burrows NR, Rolka DB, Albright A. Awareness of Prediabetes-United States, 2005-2010. MMWR. 2013;62(11):209-12. PMID: 23515058
5. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-86. doi: 10.1016/S0140-6736 (09) 61457-4 PMID: 19878986
6. Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013;56(2):284-93. doi: 10.1007/s00125-012-2752-5 PMID: 23093136
7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-89. doi: 10.1056/NEJMoa0806470 PMID: 18784090
8. Cheng YJ, Imperatore G, Geiss LS, Wang J, Saydah SH, Cowie CC, et al. Secular Changes in the Age-Specific Prevalence of Diabetes Among U. S. Adults: 1988-2010. Diabetes Care. 2013;36(9):2690-6. doi: 10.2337/dc12-2074 PMID: 23637354
9. Bullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, et al. Secular Changes in U. S. Prediabetes Prevalence Defined by Hemoglobin A1c and Fasting Plasma Glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care. 2013;36(8):2286-93. doi: 10.2337/dc12-2563 PMID: 23603918
10. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiologic Reviews. 2011;33(1):63-87.
11. Engelgau MM, Gregg EW. Tackling the global diabetes burden: will screening help? Lancet. 2012;380(9855):1716-8. doi: 10.1016/S0140-6736 (12) 61682-1 PMID: 23040423
12. Wilson JGM, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86. PMID: 8366922
14. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008;336(7654):1180-5. doi: 10.1136/bmj.39545.585289.25 PMID: 18426840
15. Chung S, Azar KM, Baek M, Lauderdale DS, Palaniappan LP. Reconsidering the age thresholds for type II diabetes screening in the U. S. Am J Prev Med. 2014;47(4):375-81. doi: 10.1016/j.amepre. 2014.05.012 PMID: 25131213
16. Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gordis L, Gregory KD, et al. Screening for type 2 diabetes mellitus in adults: U. S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2008;148(11):846-54. PMID: 18519930
17. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care. 2006;29 Suppl 1:S4-42. PMID: 16373931
18. National Institute for Health and Care Excellence. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. NICE guidelines. 2013; PH38. Available: http://www.nice.org.uk/guidance/PH38.
19. U. S. Preventive Services Task Force [Internet]. Rockville: USPSTF Program Office; [updated 2014 Oct; cited 2015 Mar. 28]. Topic Update in Progress, Abnormal Glucose and Type 2 Diabetes Mellitus in Adults: Screening; [about 2 screens]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryDraft/screening-for-abnormal-glucose-and-type-2-diabetes-mellitus.
20. Centers for Disease Control and Prevention [Internet]. Hyattsville: National Center for Health Statistics (NCHS); [updated 2105 Mar. 20; cited 2015 Mar. 28]. National Health and Nutrition Examination Survey: Questionnaires, Datasets, and Related Documentation [survey operations manuals, consent documents, brochures, and interview and exam manuals online]. Available from: http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm.
21. Centers for Disease Control and Prevention [Internet]. Hyattsville: National Center for Health Statistics (NCHS); [updated 2015 Feb. 26; cited 2015 Mar. 28]. National Health and Nutrition Examination Survey: laboratory protocol. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/lab-methods-07-08.htm.
22. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160(8):517-25. doi: 10.7326/M13-2411 PMID: 24733192
23. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation. Geneva: WHO Press; 2006. Available: http://whqlibdoc.who. int/publications/2006/9241594934-eng.pdf.
24. Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clinic Proceedings. 2010;85(1):27-35. doi: 10. 4065/mcp. 2009.0289 PMID: 20042558
25. Ratner RE. Diabetes management in the age of national health reform. Diabetes Care. 2011;34(4):1054-7. doi: 10.2337/dc10-1987 PMID: 21447668
26. Casagrande SS, Cowie CC, Fradkin JE. Utility of the U. S. Preventive Services Task Force Criteria for Diabetes Screening. AJPM. 2013;45(2):167-74.
27. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243-51. doi: 10.1016/S0140-6736 (12) 60525-X PMID: 22683134
28. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815-9. PMID: 1516497
29. Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, et al. Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes. Clin J Am Soc Nephrol. 2010;5(4):673-82. doi: 10.2215/CJN.07891109 PMID: 20338960
30. Park P, Simmons RK, Prevost AT, Griffin SJ. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. BMC Public Health. 2008;8:350. doi: 10.1186/1471-2458-8-350 PMID: 18840266
31. Eborall HC, Griffin SJ, Prevost AT, Kinmonth AL, French DP, Sutton S. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ. 2007;335(7618):486. PMID: 17761995
32. Glümer C1, Yuyun M, Griffin S, Farewell D, Spiegelhalter D, Kinmonth AL, et al. What determines the cost-effectiveness of diabetes screening? Diabetologia. 2006;49(7):1536-44. PMID: 16752172
33. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007;11(17):iii-iv, ix-xi, 1-125. PMID: 17462167
34. Diabetes Prevention Program Research Group. The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35(4):723-30. doi: 10.2337/dc11-1468 PMID: 22442395
35. Albright AL, Gregg EW. Preventing Type 2 Diabetes in Communities Across the U. S.: The National Diabetes Prevention Program. AJPM. 2013;44(4):S346-S51. doi: 10.1016/j.amepre.2012.12.009 PMID: 23498297
36. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U. S. diabetes care, 1999-2010. N Engl J Med. 2013;368(17):1613-24. doi: 10.1056/NEJMsa1213829 PMID: 23614587